UTHR · ISSUER CIK 1082554
UNITED THERAPEUTICS Corp
Between Aug 1, 2026 and Oct 29, 2026, 3 UNITED THERAPEUTICS Corp insiders reported $0.00 of open-market purchases and $338.8M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 70 of 71 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$338.8MInsider selling
−$338.8MNet open-market
Oct 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 202616:30 | Oct 28, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $585.49 | −9,500 | 324,443 | -3% | −$5.6M | ||
| Oct 29, 202616:30 | Oct 28, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 28, 202616:30 | Oct 27, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $587.73 | −9,500 | 324,443 | -3% | −$5.6M | ||
| Oct 28, 202616:30 | Oct 27, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 27, 202616:30 | Oct 26, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $588.64 | −9,500 | 324,443 | -3% | −$5.6M | ||
| Oct 27, 202616:30 | Oct 26, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 26, 202616:31 | Oct 23, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $582.76 | −9,500 | 324,443 | -3% | −$5.5M | ||
| Oct 26, 202616:31 | Oct 23, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 23, 202616:35 | Oct 22, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $583.38 | −9,500 | 324,443 | -3% | −$5.5M | ||
| Oct 23, 202616:35 | Oct 22, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 22, 202616:36 | Oct 21, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $560.07 | −9,500 | 324,443 | -3% | −$5.3M | ||
| Oct 22, 202616:36 | Oct 21, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 21, 202616:34 | Oct 20, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $553.87 | −9,500 | 324,443 | -3% | −$5.3M | ||
| Oct 21, 202616:34 | Oct 20, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 20, 202616:36 | Oct 19, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $543.32 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 20, 202616:36 | Oct 19, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 19, 202616:33 | Oct 16, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $534.66 | −9,500 | 324,443 | -3% | −$5.1M | ||
| Oct 19, 202616:33 | Oct 16, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 16, 202616:35 | Oct 15, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $546.65 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 16, 202616:35 | Oct 15, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 16, 202616:34 | Oct 15, 2026 | UTHR | EVP & GENERAL COUNSEL | S · Sell10b5-1 | $544.30 | −8,300 | 45,172 | -16% | −$4.5M | ||
| Oct 16, 202616:34 | Oct 15, 2026 | UTHR | EVP & GENERAL COUNSEL | M · Exercise10b5-1 | $146.03 | +8,300 | 53,472 | +18% | $1.2M | ||
| Oct 15, 202616:34 | Oct 14, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $539.99 | −9,500 | 324,443 | -3% | −$5.1M | ||
| Oct 15, 202616:34 | Oct 14, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 14, 202616:31 | Oct 13, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $545.52 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 14, 202616:31 | Oct 13, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 13, 202616:31 | Oct 12, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $550.70 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 13, 202616:31 | Oct 12, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 13, 202616:30 | Oct 9, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $544.94 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 13, 202616:30 | Oct 9, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 9, 202616:31 | Oct 8, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $534.31 | −9,500 | 324,443 | -3% | −$5.1M | ||
| Oct 9, 202616:31 | Oct 8, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 8, 202617:28 | Oct 7, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $548.95 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 8, 202617:28 | Oct 7, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 7, 202616:35 | Oct 6, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $538.67 | −9,500 | 324,443 | -3% | −$5.1M | ||
| Oct 7, 202616:35 | Oct 6, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 6, 202616:32 | Oct 5, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $541.64 | −9,500 | 324,443 | -3% | −$5.1M | ||
| Oct 6, 202616:32 | Oct 5, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 5, 202616:53 | Oct 2, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $549.37 | −9,500 | 324,443 | -3% | −$5.2M | ||
| Oct 5, 202616:53 | Oct 2, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 2, 202616:31 | Oct 1, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $576.47 | −9,500 | 324,443 | -3% | −$5.5M | ||
| Oct 2, 202616:31 | Oct 1, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Oct 1, 202617:30 | Oct 1, 2026 | UTHR | EVP & GENERAL COUNSEL | S · Sell10b5-1 | $564.95 | −8,300 | 45,172 | -16% | −$4.7M | ||
| Oct 1, 202617:30 | Oct 1, 2026 | UTHR | EVP & GENERAL COUNSEL | M · Exercise10b5-1 | $146.03 | +8,300 | 53,472 | +18% | $1.2M | ||
| Oct 1, 202617:22 | Sep 30, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $550.22 | −1,920 | 324,443 | -1% | −$1.1M | ||
| Oct 1, 202617:20 | Sep 30, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $517.97 | −7,580 | 326,363 | -2% | −$3.9M | ||
| Oct 1, 202617:20 | Sep 30, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Sep 30, 202616:30 | Sep 29, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $477.42 | −9,500 | 324,443 | -3% | −$4.5M | ||
| Sep 30, 202616:30 | Sep 29, 2026 | UTHR | Chairperson & CEO, Director | M · Exercise10b5-1 | $117.76 | +9,500 | 333,943 | +3% | $1.1M | ||
| Sep 29, 202616:33 | Sep 28, 2026 | UTHR | Chairperson & CEO, Director | S · Sell10b5-1 | $480.85 | −9,500 | 324,443 | -3% | −$4.6M |